AU1796083A - Carcinoembryonic antigen - Google Patents

Carcinoembryonic antigen

Info

Publication number
AU1796083A
AU1796083A AU17960/83A AU1796083A AU1796083A AU 1796083 A AU1796083 A AU 1796083A AU 17960/83 A AU17960/83 A AU 17960/83A AU 1796083 A AU1796083 A AU 1796083A AU 1796083 A AU1796083 A AU 1796083A
Authority
AU
Australia
Prior art keywords
carcinoembryonic antigen
carcinoembryonic
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17960/83A
Other languages
English (en)
Inventor
Rolf Lamerz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of AU1796083A publication Critical patent/AU1796083A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00118—Cancer antigens from embryonic or fetal origin
    • A61K39/001182—Carcinoembryonic antigen [CEA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Microbiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU17960/83A 1982-08-14 1983-08-12 Carcinoembryonic antigen Abandoned AU1796083A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19823230299 DE3230299A1 (de) 1982-08-14 1982-08-14 Carcinoembryonales antigen, verfahren zu seiner isolierung und seine verwendung
DE32302991 1982-08-14

Publications (1)

Publication Number Publication Date
AU1796083A true AU1796083A (en) 1985-02-21

Family

ID=6170888

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17960/83A Abandoned AU1796083A (en) 1982-08-14 1983-08-12 Carcinoembryonic antigen

Country Status (13)

Country Link
EP (1) EP0102008A3 (enExample)
JP (1) JPS5950360A (enExample)
AU (1) AU1796083A (enExample)
DD (1) DD211714A5 (enExample)
DE (1) DE3230299A1 (enExample)
DK (1) DK368783A (enExample)
ES (1) ES8404187A1 (enExample)
FI (1) FI832899A7 (enExample)
GR (1) GR78692B (enExample)
IL (1) IL69476A0 (enExample)
NO (1) NO832905L (enExample)
PT (1) PT77199B (enExample)
ZA (1) ZA835947B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8317022D0 (en) * 1983-06-23 1983-07-27 Erba Farmitalia Adenocarcinoma related new antigenic determinants
US6013772A (en) * 1986-08-13 2000-01-11 Bayer Corporation Antibody preparations specifically binding to unique determinants of CEA antigens or fragments thereof and use of the antibody preparations in immunoassays
US6949629B2 (en) 2002-03-13 2005-09-27 Aspenbio, Inc. Methods for purifying selected CEA family member proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663684A (en) * 1970-06-01 1972-05-16 Hoffmann La Roche Carcinoembryonic antigen and diagnostic method using radioactive iodine

Also Published As

Publication number Publication date
GR78692B (enExample) 1984-09-27
ES524909A0 (es) 1984-05-01
DD211714A5 (de) 1984-07-25
ZA835947B (en) 1984-04-25
DK368783D0 (da) 1983-08-12
ES8404187A1 (es) 1984-05-01
FI832899L (fi) 1984-02-15
JPS5950360A (ja) 1984-03-23
EP0102008A3 (de) 1987-01-28
IL69476A0 (en) 1983-11-30
EP0102008A2 (de) 1984-03-07
PT77199A (de) 1983-09-01
DE3230299A1 (de) 1984-02-16
PT77199B (de) 1986-03-27
NO832905L (no) 1984-02-15
DK368783A (da) 1984-02-15
FI832899A0 (fi) 1983-08-11
FI832899A7 (fi) 1984-02-15

Similar Documents

Publication Publication Date Title
AU1383083A (en) Ligator-clip
AU1761783A (en) Photoradiator
AU1115783A (en) Quadricycle
AU1659483A (en) 14-fluoromorphinans
AU1112583A (en) Pyrazolo-quinolines, -thiazines and -oxazines
AU1557383A (en) Hestesko
AU1708883A (en) Ratschenartiger maulschlussel
AU1602483A (en) Sectionaliser
AU1475883A (en) Dosierpumpe
AU1395383A (en) Benzoazacycloalkyl-spiro-imidazolidines
AU1636583A (en) 19-thio-androstanes
AU1476983A (en) Bomanordning
AU1704883A (en) Pferdehufschuh
AU1471483A (en) Tallerkenknuser
AU1995683A (en) 4-methyl-5-alkylthiomethylimidazoles
AU1553583A (en) Arbeitsmaschine
AU569466B2 (en) Polysiloxanes
AU1824183A (en) Schneckenpresse
AU1825983A (en) Skjellklase-skilleanordning
AU1796083A (en) Carcinoembryonic antigen
AU1277283A (en) N-substituted-tetrahydrothiazines
AU1222883A (en) Transmissionsmekanisme
AU1087683A (en) Oxazolidin-2-ones
AU1416683A (en) Sulphinyl - and sulphonyl - azacycloheptan - 2 - ones
AU1305283A (en) Elevator-conveyor